PharmTrain2
Background
Global health crises are on the rise, especially those caused by infectious disease outbreaks, and pose a serious threat to health and well-being. The World Health Organization (WHO) estimates that up to 10 million lives could be saved every year if access to safe and effective medicines and vaccines were improved. As a World Health Assembly resolution on this subject highlights, stable, well-functioning health care systems are urgently needed to ensure timely access to quality medical products, which will help countries prevent and respond effectively to health crises. Despite considerable advances in recent years, the capacity to improve access to essential medical products through efficient regulation is still limited in many regions, including sub-Saharan Africa.
Aim
The GHPP PharmTrain2 project of the BfArM aims to strengthen regulatory infrastructure and the capacity of partnering authorities to evaluate the pharmaceutical quality, efficacy and safety of medicinal products. This will improve the quality, consistency and efficiency of regulatory decision-making. PharmTrain2 also strongly promotes medicines regulation harmonisation in Africa. The activities build on the achievements of the GHPP RegTrain-PharmTrain project and involve working with staff from the medicines regulatory authorities in the seven partner countries (project partners) and supporting African Union Development Agency, New Partnership for Africa’s Development (AUDA-NEPAD) in operationalising the African Medicines Agency (AMA).
Pillars
Reports
Project partners
Resources
Contact
Regine Lehnert, Project Lead
Federal Institute for Drugs and Medical Devices (BfArM)
Kurt-Georg-Kiesinger Allee 3
53175 Bonn, Germany
E-mail: ghpp.pharmtrain@bfarm.de